NEW YORK, Sept. 1, 2023 /PRNewswire/ -- The neuromyelitis optica spectrum disorder market to grow by USD 173.48 million at a CAGR of 6.16% from 2022 to 2027, according to the latest research report ...

Los Angeles, USA, Aug. 04, 2021 (GLOBE NEWSWIRE) -- A Robust Neuromyelitis Optica Spectrum Disorder Pipeline Domain Witnesses Several Novel and Promising Therapies in Different Stages of Clinical ...

The goal of this retrospective study was to assess the diagnostic value and clinical characteristics of painful tonic spasm (PTS) in patients with neuromyelitis optica (NMO). At 2 referral hospitals, ...

Joanna Robles, MD, first began having unusual symptoms in the summer of 2020. She had bouts of nausea and vomiting that she couldn’t explain. Eventually doctors diagnosed her with neuromyelitis optica ...

The drug eculizumab, a synthetic antibody that inhibits the inflammatory response, significantly reduced the risk of relapse with neuromyelitis optica spectrum disorder (NMOSD). This rare but severe ...

In 1999, Wingerchuk et al. proposed the following diagnostic criteria for Devic's neuromyelitis optica (NMO): optic neuritis, acute myelitis, and no symptoms implicating CNS involvement beyond the ...

A systematic review identified 15 studies, enabling a meta-analysis of 443 NMOSD patients with 639 pregnancies. Rates of pregnancy-related NMOSD relapses were highest during the first 3 months ...

Neuromyelitis optica spectrum disorder (NMOSD) is an autoimmune disorder that mostly affects your eyes and spinal cord. Your immune system attacks a specific protein, called aquaporin-4 (AQP4). The ...

Please provide your email address to receive an email when new articles are posted on . Two new studies have shown promising data supporting the use of eculizumab or satralizumab to significantly ...

Neuromyelitis optica (NMO) can be a devastating rare disease, but a lack of awareness among doctors means patients are often misdiagnosed for years, while research into cures is sparse. After being ...

Background: In 70-80% of cases, neuromyelitis optica (NMO) is associated with highly specific serum auto-antibodies to aquaporin-4 (termed AQP4-Ab or NMO-IgG). Recent evidence strongly suggests that ...

The combination of optic neuritis and myelitis, the so-called Neuromyelitis optica is an uncommon pattern of demyelinating disorder. In 1870, Sir Thomas Clifford Allbutt first reported the association ...